Search Login Register

golimumab Summary

Description: Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX.

Also Known As: Simponi

Networked: 245 relevant articles (61 outcomes, 93 trials/studies) for this Drug

Key Diseases for which golimumab is Relevant

  1. Rheumatoid Arthritis : 14 outcomes 45 studies in 105 results
  2. Ulcerative Colitis : 11 outcomes 7 studies in 28 results
  3. Psoriatic Arthritis : 10 outcomes 18 studies in 53 results
  4. Ankylosing Spondylitis : 8 outcomes 20 studies in 51 results
  5. Psoriasis (Pustulosis Palmaris et Plantaris) : 6 outcomes 5 studies in 28 results
Show All >>

Drugs Related to golimumab

  1. adalimumab (Humira)
  2. infliximab (Remicade)
  3. Methotrexate (Mexate)
  4. TNFR-Fc fusion protein (etanercept)
  5. CDP870
  6. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  7. tocilizumab
  8. monoclonal antibody CNTO 1275 (CNTO 1275)
  9. abatacept (BELATACEPT)
  10. vedolizumab
Show All >>

Therapies Related to golimumab

  1. Aftercare (After-Treatment)
  2. Remission Induction
  3. Subcutaneous Injections
  4. Investigational Therapies (Experimental Therapy)
  5. Stents
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.